Brind.
  1. PureTech Ventures launched Celea, a new respiratory disease treatment, with Sven Dethlefs appointed to lead its program advancement.

Leadership appointments at PureTech Ventures include the appointment of Robert Lyne as Interim CEO and Sharon Barber-Lui as Interim Chair of the Board.

1 report, 1 independent Updated Jul 16
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Leadership appointments at PureTech Ventures include the appointment of Robert Lyne as Interim CEO and Sharon Barber-Lui as Interim Chair of the Board.

Who's involved

What this event is mainly about
PureTech Ventures

Keep exploring

Part of

PureTech Ventures launched Celea, a new respiratory disease treatment, with Sven Dethlefs appointed to lead its program advancement. All 1 developments

The entities involved

Coverage

Newest first; wire copies grouped
  • Business WirePureTech Announces Leadership Transition BOSTON, July 16, 2025--(BUSINESS WIRE)--PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company